Olsutamig is a bivalent humanized IgG4kappa monoclonal antibody inhibitor targeting FOLH1/PSMA and CD3E. It is capable of binding simultaneously to PSMA on tumor cell surfaces and CD3E on T cell surfaces, leading to significant activation of T cells and the specific destruction of prostate cancer cells.
CAS Number:
[3034664-43-9]
Target:
PSMA|||Integrin
* VAT and and shipping costs not included. Errors and price changes excepted
